QQ客服 官方微博 反馈留言

	Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol Versus Standard Dual Antiplatelet in Patients With High Posttreatment Platelet Reactivity Results of the CREATIVE Trial
	Tang, Yi-Da; Wang, Wenyao; Yang, Min; Zhang, Kuo; Chen, Jing; Qiao, Shubin; Yan, Hongbing; Wu, Yongjian; Huang, Xiaohong; Xu, Bo
	2018
卷号	137期号:21页码:2231-2245
关键词	cilostazol clopidogrel percutaneous coronary intervention platelet aggregation inhibitors platelet function test
ISSN号	0009-7322
DOI	10.1161/CIRCULATIONAHA.117.030190
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6359202
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Tang, Yi-Da,Wang, Wenyao,Yang, Min,et al. Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol Versus Standard Dual Antiplatelet in Patients With High Posttreatment Platelet Reactivity Results of the CREATIVE Trial[J],2018,137(21):2231-2245.
APA	Tang, Yi-Da.,Wang, Wenyao.,Yang, Min.,Zhang, Kuo.,Chen, Jing.,...&Yang, Yuejin.(2018).Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol Versus Standard Dual Antiplatelet in Patients With High Posttreatment Platelet Reactivity Results of the CREATIVE Trial.,137(21),2231-2245.
MLA	Tang, Yi-Da,et al."Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol Versus Standard Dual Antiplatelet in Patients With High Posttreatment Platelet Reactivity Results of the CREATIVE Trial".137.21(2018):2231-2245.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。